{"id":17875,"date":"2021-03-23T08:24:19","date_gmt":"2021-03-23T12:24:19","guid":{"rendered":"https:\/\/medicarereport.org\/?p=17875"},"modified":"2021-03-23T08:24:19","modified_gmt":"2021-03-23T12:24:19","slug":"astrazeneca-may-have-used-outdated-information-in-announcing-results-from-covid-19-vaccine-trial-u-s-officials-say","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=17875","title":{"rendered":"AstraZeneca may have used \u2018outdated information\u2019 in announcing results from Covid-19 vaccine trial, U.S. officials say"},"content":{"rendered":"<p>(By Andrew Joseph for ST<em>A<\/em>T)<\/p>\n<p>U.S. health officials raised concerns early Tuesday that positive results that AstraZeneca announced Monday for its Covid-19 vaccine may have been based on \u201can incomplete view of the efficacy data\u201d from a clinical trial and relied on \u201coutdated information,\u201d throwing another curveball in the saga of the company\u2019s vaccine.\u00a0 Continue reading the article<a href=\"https:\/\/www.statnews.com\/2021\/03\/23\/astrazeneca-may-have-used-outdated-information-in-announcing-covid19-vaccine-results\/\"> here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Andrew Joseph for STAT) U.S. health officials raised concerns early Tuesday that positive results that AstraZeneca announced Monday for<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,15],"tags":[],"class_list":["post-17875","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17875"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17875\/revisions"}],"predecessor-version":[{"id":17876,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17875\/revisions\/17876"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}